| Clinical data | |
|---|---|
| Other names | Tozalinone, Thozalinon |
| Routes of administration | Oral |
| ATC code |
|
| Legal status | |
| Legal status |
|
| Identifiers | |
| |
| CAS Number |
|
| PubChemCID | |
| ChemSpider |
|
| UNII | |
| KEGG |
|
| ChEMBL | |
| CompTox Dashboard(EPA) | |
| Chemical and physical data | |
| Formula | C11H12N2O2 |
| Molar mass | 204.229 g·mol−1 |
| 3D model (JSmol) | |
| Chirality | Racemic mixture |
| |
| |
| | |
Thozalinone (USAN) (brand nameStimsen; former developmental code nameCL-39808) is apsychostimulant that has been used as anantidepressant inEurope.[1][2][3][4][5] It has also beentrialed as ananorectic.[6] Thozalinone is described as a "dopaminergic stimulant",[7] and likely acts via inducing therelease ofdopamine and to a minimal extentnorepinephrine; similar toanaloguepemoline, it is reportedly devoid of abuse potential unlike other dopaminergic psychostimulants.[2][7][8]

Sodium hydride is used as a strong base to abstract the alcohol proton in ethyl mandelate [774-40-3] (1); addition of the oxyanion to dimethylcyanamide [1467-79-4] gives the intermediate (2). Intramolecular cyclization then occurs giving Thozalinone (3).